Clinical Trials Logo

Filter by:
NCT ID: NCT03889262 Not yet recruiting - Cerebral Palsy Clinical Trials

Development of Simulated Hippotherapy System and Investigation of Its Effectiveness in Children With Cerebral Palsy

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to develop a simulated hippotherapy system controlled by electromyography (EMG) signals and investigate its effectiveness in children with cerebral palsy. In order to investigate its effectiveness evaluation of gross motor functions, lower extremity joint movements, spasticity of the lower extremities, functional independence, body movements, sitting and standing balance, muscle tone, stiffness and elasticity level, analysis of the walking are planned.

NCT ID: NCT03889938 Not yet recruiting - Psoriasis Clinical Trials

Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis

Start date: April 1, 2019
Phase:
Study type: Observational

1. Assess the level of lipid mediators in patients with psoriasis 2. Assess the urinary level of biopyrins as New marker of oxidative stress in patients with psoriasis 3. Correlate the serum level of bioactive lipid mediators and urinary level of biopyrins with Psoriasis Area and Severity Index

NCT ID: NCT03890055 Not yet recruiting - Clinical trials for Small Cell Lung Cancer

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Start date: April 1, 2019
Phase: Phase 4
Study type: Interventional

This study was designed to investigate the efficacy and side effects of combining erlotinib with classical EC/EP chemotherapy regimens.

NCT ID: NCT03890159 Not yet recruiting - Stroke Clinical Trials

Effects of Computer Assisted Cognitive Rehabilitation on Patients With Stroke

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This study aims to investigate the effects of computer assisted cognitive rehabilitation and conventional cognitive rehabilitation methods on patients' attention, quality of life and functional independence. Recruiting from 15 patients from each group, patients will be followed up for a month and the outcome measures will be repeated.

NCT ID: NCT03890549 Not yet recruiting - Snoring Clinical Trials

Validation of Downloadable Mobile Snore Applications by Polysomnography (PSG)

Start date: April 1, 2019
Phase:
Study type: Observational

The aim of this study is to validate the downloadable mobile snore applications by polysomnography.

NCT ID: NCT03890692 Not yet recruiting - Adenoid Hypertrophy Clinical Trials

Methods of Assessment of Adenoid Size

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Chronic nasal obstruction due to adenoid hypertrophy is among the most common health problems affecting children, and adenoidectomy is one of the most common surgical procedures performed in this age group Because of difficulties associated with the use of the objective methods (such as nasopharyngeal endoscopy) in young children, the development of a reliable scale based on the child's symptoms to properly evaluate the need for surgical intervention would be of great value for clinicians. When adenoidectomy is being considered, the diagnosis and documentation of adenoidal hypertrophy become an important issue. Numerous modalities have been used for this task, including trans oral digital palpation and trans oral mirror examination; however, these methods are quite impractical with uncooperative younger children

NCT ID: NCT03891212 Not yet recruiting - Severe Pneumonia Clinical Trials

The Effect of Prone Position Drainage on the Efficacy of Severe Pneumonia,a Multicenter Randomized Controlled Trial

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Enrollment criteria and clinical data collection: follow the principles of medical ethics, the development of inclusion and exclusion criteria, Select all eligible patients with severe pneumonia(SP) who were admitted to the hospital during the study date.The diagnostic criteria we will use for SP are based on the Infectious Diseases Society of America/American Thoracic Society guidelines.Primary outcome measures:a.CURB-65 Score for Pneumonia Severity;b.The changes in inflammation and coagulation indicators: C-reactive protein, procalcitonin, and d-dimer;c.Chest x-ray changes;d.Mortality rate after 28 days;e.The time of mechanical ventilation, total duration of ICU stay, hospitalization, and antibiotic use;f.The time of bacterial cultures becoming negative;g.Daily sputum drainage.The aim of this study is to evaluate the anti-infective effectiveness and safety of prone position drainage compared with supine position on SP treatment.

NCT ID: NCT03891394 Not yet recruiting - Preeclampsia Clinical Trials

Human Epididymis Protein 4 in Women With Severe Preeclampsia / HELLP Syndrome

Start date: April 1, 2019
Phase:
Study type: Observational

Pre-eclampsia seems to be associated with a four to five times increase risk of later microalbuminuria and CKD which might suggest a possible direct renal damage from pre-eclampsia

NCT ID: NCT03892590 Not yet recruiting - Microbiota Clinical Trials

Gut Microbiota Pilot Study

Start date: April 1, 2019
Phase:
Study type: Observational [Patient Registry]

Microbiota is known to effect metabolism. This is pilot study to get status of microbiota from normal control. It will be compared to data from specific patients in ICU via further study.

NCT ID: NCT03892850 Not yet recruiting - Acute Disease Clinical Trials

Effectiveness and Safety of the Nursing Prescription in Acute Health Problems of Low Complexity

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Objective: To compare the efficacy/effectiveness of pharmacological nurse prescription with medical prescription in patients attended in a primary care center for minor acute health problems. Scope of the study: Multicenter study, with the participation of 8 primary care centers of Catalonia. Methodology: Randomized blind clinical trial, with experimental group receiving pharmacological nurse prescription and a control group receiving medical prescription. Subjects are individuals who request a same day consultation for minor acute pathologies and meet the selection criteria, with random assignment of 374 subjects, 187 per group. The efficacy/effectiveness of the prescribed treatment will be considered as a no re-attendance during the following 72h and will be completed with the variables: information and knowledge of the treatment, adverse effects, compliance, satisfaction level and resolution of the health problem. The data collection is done 10 days after the visit by an ad-hoc telephone questionnaire of 11 items, previously tested. The analysis is done using the SPSS software version 21.0, obtaining data of descriptive, multivariate and inferential statistics. Implications for practice: To evidence the equivalence of pharmacological nurse prescription with medical prescription for minor acute health problems